Výsledky vyhledávání - "Yehia El Shazly"

Akademický článek

Obesity prevalence in adults and patients with hepatitis C: results from screening a population of 50 million in Egypt

Publikováno v: Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-13 (2024)

Abstract Obesity is a global health problem and has been increasing in Egypt over the last several decades. A national population screening program for hepatitis C included screening for obesity. Here we report the outcome of body mass index (BMI) ca

Externí odkaz: https://doaj.org/article/15e05e44373e4f3a82c179f9968f1246

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience

Autor: Mira Atef, Rasha Eletreby, Mohamed Abdallah, Rasha Salama, Wafaa Elakel, Mohamed Hassany, Wael Abdel-Razek, Yehia El Shazly, Wahid Doss, Gamal Esmat

Publikováno v: Egyptian Liver Journal, Vol 12, Iss 1, Pp 1-6 (2022)

Abstract Background Outcome of HCV treatment with direct antiviral agents in malignant patients is questionable. The aim is to assess the safety and efficacy of DAAs in treatment of chronic HCV patients who received chemotherapy for malignancies. Mat

Externí odkaz: https://doaj.org/article/e3fc586659d843f2bbd997e2f55d444b

Zobrazit plný text záznamu

Plný text ve formátu HTML

Direct-acting antiviral regimens in Egyptian patients with chronic hepatitis C virus infection: A real-world single-center experience

Autor: Gina Gamal Naguib, Mohamed Hassan, Ossama A. Ahmed, Magdy El-Serafy, Yehia El Shazly, Mohamed Shaker, Eslam Safwat, Ahmed F Sherief, A.M. Farid, Ahmed I. Elshafie, Haitham Ezzat, Manal H El-Sayed, Mohamed Hassany, Hany Dabbous

Publikováno v: Arab Journal of Gastroenterology. 22:285-291

Background and study aims: Chronic hepatitis C virus (HCV) infection has always been identified as a major health threat and a potential cause of liver cirrhosis , portal hypertension , and other associated problems. The introduction of direct-acting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f83a45185ced4ce1d0bdcd8a9a7a2da1
https://doi.org/10.1016/j.ajg.2021.06.001

Zobrazit plný text záznamu

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

Autor: Gamal Esmat, Manal H El-Sayed, Mahmoud Shedeed, Imam Waked, Yehia El Shazly, Wafaa El Akel, Ashraf Omar Abdelaziz, Shereen Abdel Alem, Wahid Doss, Dina H. Ziada, Mohamed El Kassas, Rabab Salama, Magdy El-Serafy, Mahmoud Anees, Aisha Elsharkawy, Fatma Mohamed Abd-Elsalam

Publikováno v: Expert Review of Gastroenterology & Hepatology. 13:1009-1016

Objectives: To assess the role of baseline liver stiffness (LS) by Transient elastography (TE) and FIB-4 in the prediction of virological response to sofosbuvir - based regimens in chronic HCV patients.Methods: A retrospective, multicenter study incl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6989a425de5cf41925498d94108ba0dd
https://doi.org/10.1080/17474124.2019.1653183

Zobrazit plný text záznamu

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

Autor: Yehia El Shazly, Ahmed A. Gomaa, Wafaa El-Akel, Mai Mehrez, Mohamed Abdullah, Mahamed El Kassas, Heba Omar, Maissa El Raziky, Imam Waked, Samar K Darweesh, Wahid Doss, Gamal Esmat, Kadry Elsaeed, Mohammed Shaker, Magdy El-Serafy, Sohier Ahmed Ismail

Publikováno v: Expert review of gastroenterologyhepatology. 13(9)

Aim: Evaluation of the efficacy and safety of sofosbuvir/daclatasvir/ribavirin (SOF/DCV/RBV) in treating non-sustained virological responders (non-SVR12) to prior sofosbuvir-based therapy, in absence of RAS testing in mass treatment, and determinatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa73b926455cf0a7378bd7f8b4d6af9
https://pubmed.ncbi.nlm.nih.gov/31173527

Zobrazit plný text záznamu

Assessment of Serum Retinol Binding Protein 4 in Patients with Hepatocellular Carcinoma

Autor: Yehia El Shazly, Reham Ezzat Al Swaff, Hany Samir Rasmy, Hany Ali Hussein, Moataz Aly Ahmad, Mohamed Abd El Moghny

Publikováno v: Journal of Clinical and Diagnostic Research, Vol 12, Iss 10, Pp OC27-OC31 (2018)

Introduction: Retinol Binding Protein 4 (RBP4) may be indirectly involved in the induction of carcinogenesis as it was identified as a key regulator of insulin resistance in obesity and diabetes. Data about serum level of RBP4 in patients with Hepato

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f958339ab26dbde3a0f3ee3ae9aa3f7d

Zobrazit plný text záznamu

An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens

Autor: Wahid Doss, Heba Omar, Enass Moaz, Gamal Esmat, Mohamed El Kassas, Mahmoud Abouelkhair, Dalia Omran, Mohamed Elbadry, Shimaa Afify, Mohamed Alboraie, Kadry Elsaeed, A.M. Farid, Adel El Tahan, Mohamed-Naguib Wifi, Mohamed Salaheldin, Yehia El Shazly, Sameera Ezzat

Publikováno v: Expert review of gastroenterologyhepatology. 12(12)

A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3a7c63530465873f23f80da1971e33a
https://pubmed.ncbi.nlm.nih.gov/29757684

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání